Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576104, Karnataka, India.
Curr Drug Targets. 2021;22(10):1121-1128. doi: 10.2174/1389450122666210120125945.
Statins have transformed the treatment of cardiovascular diseases through primary and secondary prevention of events. Despite the success of statin's management of cardiovascular conditions, certain clinical trials, reviews, and meta-analysis point out that statins have the propensity to induce diabetes. The risk further increases with intensive statin therapy or in patients with diabetes. A proper mechanism for the induction of the diabetic condition has not yet been determined. The involvement of statin with beta cells in insulin secretion and peripheral cells in insulin resistance has been widely studied and established. The present review provides an update on the recent understanding of statin-induced diabetes. This covers the origin of statins, their development, possible mechanisms that explain the adverse effects in glucose homeostasis, and probable targets to remedy the condition.
他汀类药物通过心血管疾病的一级和二级预防改变了治疗方法。尽管他汀类药物在心血管疾病的管理方面取得了成功,但某些临床试验、综述和荟萃分析指出,他汀类药物有诱发糖尿病的倾向。风险会随着强化他汀类药物治疗或糖尿病患者的增加而进一步增加。目前尚未确定诱导糖尿病的具体机制。他汀类药物与β细胞胰岛素分泌和外周细胞胰岛素抵抗的关系已得到广泛研究和证实。本综述提供了他汀类药物诱导糖尿病的最新认识。内容涵盖了他汀类药物的起源、发展、解释其对葡萄糖稳态产生不良影响的可能机制以及可能的治疗靶点。